Cardinal Health, Inc. (NYSE:CAH) Receives Average Recommendation of “Moderate Buy” from Analysts

Shares of Cardinal Health, Inc. (NYSE:CAH) have received a consensus rating of “Moderate Buy” from the seventeen brokerages that are currently covering the stock, MarketBeat.com reports. Two investment analysts have rated the stock with a hold rating, fourteen have assigned a buy rating and one has given a strong buy rating to the company. The average 1 year target price among brokers that have issued a report on the stock in the last year is $246.9286.

A number of brokerages have issued reports on CAH. William Blair began coverage on Cardinal Health in a research note on Tuesday, April 28th. They issued an “outperform” rating on the stock. Wells Fargo & Company decreased their price target on Cardinal Health from $256.00 to $245.00 and set an “overweight” rating on the stock in a research note on Friday, May 1st. Zacks Research raised Cardinal Health from a “hold” rating to a “strong-buy” rating in a research note on Thursday, February 12th. Argus raised their price target on Cardinal Health from $232.00 to $248.00 and gave the stock a “buy” rating in a research note on Wednesday, February 11th. Finally, Weiss Ratings lowered Cardinal Health from a “buy (b+)” rating to a “buy (b)” rating in a research note on Tuesday, May 19th.

Cardinal Health Stock Up 1.5%

CAH opened at $215.77 on Friday. The business’s fifty day simple moving average is $202.77 and its 200 day simple moving average is $208.66. Cardinal Health has a 52 week low of $137.75 and a 52 week high of $233.60. The firm has a market cap of $50.54 billion, a P/E ratio of 32.99, a PEG ratio of 1.16 and a beta of 0.52.

Cardinal Health (NYSE:CAH) last issued its quarterly earnings results on Thursday, April 30th. The company reported $3.17 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $2.79 by $0.38. Cardinal Health had a negative return on equity of 92.61% and a net margin of 0.62%.The firm had revenue of $60.94 billion for the quarter, compared to analyst estimates of $62.10 billion. During the same period last year, the company earned $2.35 EPS. The firm’s quarterly revenue was up 11.0% on a year-over-year basis. Cardinal Health has set its FY 2026 guidance at 10.700-10.80 EPS. As a group, equities analysts expect that Cardinal Health will post 10.76 EPS for the current fiscal year.

Cardinal Health Increases Dividend

The company also recently disclosed a quarterly dividend, which will be paid on Wednesday, July 15th. Stockholders of record on Wednesday, July 1st will be paid a $0.5158 dividend. The ex-dividend date of this dividend is Wednesday, July 1st. This represents a $2.06 annualized dividend and a dividend yield of 1.0%. This is an increase from Cardinal Health’s previous quarterly dividend of $0.51. Cardinal Health’s dividend payout ratio is presently 31.19%.

Hedge Funds Weigh In On Cardinal Health

Hedge funds and other institutional investors have recently modified their holdings of the company. Aventura Private Wealth LLC acquired a new position in shares of Cardinal Health in the 4th quarter valued at about $25,000. University of Texas Texas AM Investment Management Co. acquired a new position in shares of Cardinal Health in the 4th quarter valued at about $26,000. Bank of Jackson Hole Trust acquired a new position in shares of Cardinal Health in the 4th quarter valued at about $27,000. Jones Financial Companies Lllp lifted its stake in shares of Cardinal Health by 198.3% in the 1st quarter. Jones Financial Companies Lllp now owns 21,112 shares of the company’s stock valued at $27,000 after purchasing an additional 14,034 shares in the last quarter. Finally, Palladiem LLC acquired a new position in shares of Cardinal Health in the 4th quarter valued at about $28,000. 87.17% of the stock is owned by institutional investors and hedge funds.

About Cardinal Health

Cardinal Health is a multinational healthcare services and products company headquartered in Dublin, Ohio. Tracing its roots to the early 1970s, the company has grown into a major provider of supply chain and distribution services for the healthcare sector. Cardinal Health operates across a range of service lines that support hospitals, health systems, pharmacies, physician offices and clinical laboratories.

The company’s core activities include the wholesale distribution of branded and generic pharmaceuticals, the supply and distribution of medical-surgical products, and the provision of logistics and inventory management solutions.